本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流。活动时间为 2023 年 5 月 12 日（周五）15:00-17:00。届时公司 董事长兼总经理谢宏先生、独立董事胡军辉先生、财务总监金志强先生、董事会 秘书李志容女士（如遇特殊情况，参会人员将有调整）将在线就公司 2022 年度 业绩、公司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等投 资者关心的问题，与投资者进行沟通与交流，欢迎广大投资者踊跃参与！ 为提高互动交流的效率，现提前向所有关心公司的投资者公开征集交流问题， 广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 11 日（星期四）17:00 前访问 http://ir.p5w.net/zj/，或扫描下方二维码，进入问题征集专题页面，提交您 所关心的问题。 （互动交流问题征集专题页面二维码） 特此公告。 贝因美股份有限公司 关于参加浙江辖区上市公司 2023 年投资者网上集体接待日活动 暨 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信 ...

证券代码：002570 证券简称：贝因美 公告编号：2023-044 关于参加浙江辖区上市公司 2023 年投资者网上集体接待日活动 贝因美股份有限公司 暨 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 贝因美股份有限公司（以下简称"公司"）2022 年年度报告已于 2023 年 4 月 29 日披露，为进一步加强与投资者的互动交流，公司将参加由浙江证监局、 浙江省上市公司协会与深圳市全景网络有限公司联合举办的"2023 年浙江辖区 上市公司投资者集体接待日活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （https://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP，参 与本次互动交流。活动时间为 2023 年 5 月 12 日（周五）15:00-17:00。届时公司 董事长兼总经理谢宏先生、独立董事胡军辉先生、财务总监金志强先生、董事会 秘书李志容女士（如遇特殊情况，参会人员将有调整）将在线就公司 2022 年度 业绩、公司治理、发展战略、经营状况 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥1,399,938,197.45, representing a 24.83% increase compared to ¥1,121,481,666.83 in the same period last year[24]. - The net profit attributable to shareholders of the listed company was ¥42,914,990.66, up 28.01% from ¥33,524,658.31 in the previous year[24]. - The net profit after deducting non-recurring gains and losses increased by 60.08%, reaching ¥27,356,468.67 compared to ¥17,088,924.55 in the same period last year[24]. - The net cash flow from operating activities surged by 412.18%, amounting to ¥186,103,264.43, compared to ¥36,335,620.30 in the previous year[24]. - Basic earnings per share rose to ¥0.04, a 33.33% increase from ¥0.03 in the same period last year[24]. - Total revenue for the reporting period reached ¥1,399,938,197.45, representing a year-on-year increase of 24.83% compared to ¥1,121,481,666.83 in the same period last year[58]. - The company reported a total comprehensive income for the first half of 2022 of CNY 43,719,463.40, which includes a net profit of CNY 42,914,990.66[186]. - The total comprehensive income for the first half of 2022 was CNY 40,962,410.80, reflecting an increase of 2,896,946.15 compared to the previous period[190]. Assets and Liabilities - Total assets at the end of the reporting period were ¥4,079,980,580.69, reflecting a 0.26% increase from ¥4,069,421,166.85 at the end of the previous year[24]. - The total assets as of June 30, 2022, amounted to ¥4,785,689,523.06, compared to ¥4,612,473,272.99 at the beginning of the year, indicating an increase of 3.8%[166]. - The total liabilities as of June 30, 2022, were ¥2,669,442,398.12, up from ¥2,519,631,052.61 at the start of the year, representing a growth of 5.9%[166]. - The company's total liabilities were CNY 1,022,520,000.00, reflecting a significant portion of the total assets[194]. - The company's cash and cash equivalents at the end of the reporting period were CNY 253,993,951.66, which is crucial for liquidity management[194]. Revenue Breakdown - Revenue from milk powder products was ¥1,190,471,160.39, accounting for 85.04% of total revenue, with an 18.20% increase from ¥1,007,187,511.03[59]. - The sales revenue of children's powder increased by 286% year-on-year, while the sales of special medical formula milk powder grew by over 62.40%[37]. - The gross profit margin for the main business was 48.55%, with a year-on-year revenue change of 16.44%[41]. - The gross profit margin for the infant industry was 43.85%, down 9.75% from the previous year, with costs rising by 51.07%[60]. Investments and R&D - The company holds 21 invention patents and has registered 60 infant formula products, showcasing its strong R&D capabilities[48]. - Research and development expenses decreased by 28.95% to ¥10,698,461.48 from ¥15,058,142.75 in the previous year[55]. - The company is actively exploring precise nutrition formula products and other related services to address the risk of declining newborn population[86]. - The company has initiated research and development efforts for new technologies aimed at improving operational efficiency[191]. Shareholder and Equity Information - The total number of ordinary shareholders at the end of the reporting period was 74,300[146]. - The company’s major shareholder, Beiyinmei Group, reduced its holdings by 10.8 million shares, representing 0.9999% of the total share capital, and currently holds 201,418,500 shares, or 18.65%[140]. - The total equity attributable to shareholders at the end of the reporting period was CNY 1,536,709,519.15, with a decrease of CNY 980,002,691.94 from the beginning of the year[194]. - The retained earnings at the end of the period were CNY -532,275,686.03, indicating accumulated losses[199]. Operational Highlights - The company has established a new retail business model that integrates online and offline sales channels[40]. - The number of distributors increased from 1,526 at the end of 2021 to 1,685 by June 2022, marking a 10% growth[42]. - The company has committed to using raised funds according to regulatory requirements and its own distribution plan[79]. - The company is implementing effective supply chain management to mitigate related risks and ensure inventory control[87]. Compliance and Governance - The company emphasizes the importance of regulatory compliance and has urged subsidiaries to enhance operational standards to prevent similar investment issues in the future[134]. - The company is focused on maintaining compliance with environmental regulations and has established a comprehensive environmental management system[98]. - The company has not reported any changes in the use of raised funds or any issues in their disclosure[80]. Social Responsibility - The company donated 294 boxes of infant nutrition products valued at over 310,000 yuan to the Shanghai Fosun Public Welfare Foundation during the reporting period[99].

Financial Performance - The company's operating revenue for Q1 2023 was ¥717,274,967.43, a decrease of 3.04% compared to ¥814,448,112.17 in the same period last year[3]. - The net profit attributable to shareholders decreased by 39.13% to ¥12,250,864.35 from ¥20,126,374.67 year-on-year[3]. - The net profit after deducting non-recurring gains and losses dropped by 74.40% to ¥3,972,825.65 compared to ¥15,517,744.73 in the previous year[3]. - The total operating revenue for the first quarter of 2023 was CNY 717,274,967.43, an increase from CNY 696,112,450.13 in the same period last year, representing a growth of approximately 1.67%[26]. - The net profit for the first quarter of 2023 was CNY 13,837,189.83, a decrease from CNY 20,984,457.67 in the previous year, reflecting a decline of approximately 34%[26]. - The net profit attributable to the parent company for Q1 2023 was CNY 12,250,864.35, a decrease from CNY 20,126,374.67 in the same period last year, representing a decline of approximately 39.1%[27]. - The total comprehensive income attributable to the parent company was CNY 17,024,071.02, compared to CNY 16,283,924.71 in the previous year, showing an increase of about 4.5%[27]. Cash Flow - The net cash flow from operating activities decreased by 55.10% to ¥23,750,966.73 from ¥52,895,828.43 year-on-year[3]. - The company reported a significant decrease in cash received from operating activities, down 63.26% to ¥1,804.05 million, mainly due to reduced recoveries of operating deposits[11]. - Cash inflows from operating activities totaled CNY 752,979,771.67, up from CNY 709,547,323.73 year-over-year, indicating a growth of approximately 6.1%[30]. - The net cash flow from operating activities decreased to CNY 23,750,966.73 from CNY 52,895,828.43, reflecting a decline of about 55.8%[30]. - The cash flow from financing activities decreased by 84.5% to ¥38,601.96 million, primarily due to reduced bank borrowings compared to the previous year[12]. - The net cash flow from financing activities was negative at CNY -26,579,720.89, compared to CNY -31,319,485.85 in the previous year, showing an improvement of about 15.5%[31]. - Cash outflows from investing activities amounted to CNY 29,791,043.11, down from CNY 57,858,101.19, a reduction of approximately 48.6%[30]. Assets and Liabilities - The total assets at the end of the reporting period increased by 0.54% to ¥3,898,115,578.61 from ¥3,877,108,863.41 at the end of the previous year[3]. - The company's total assets as of March 31, 2023, amounted to CNY 3,898,115,578.61, compared to CNY 3,877,108,863.41 at the beginning of the year, showing a slight increase of about 0.54%[24]. - The total liabilities increased to CNY 2,304,620,657.89 from CNY 2,285,997,270.56, marking an increase of approximately 0.76%[24]. Shareholder Information - Total number of ordinary shareholders at the end of the reporting period was 75,946[15]. - The largest shareholder, Beiyinmei Group Co., Ltd., holds 18.19% of shares, totaling 196,418,500 shares, with 194,850,000 shares pledged[15]. - The company repurchased 28,412,298 shares, accounting for 2.63% of the total share capital[16]. Corporate Actions and Developments - The company plans to support the establishment of an industrial incubation fund by its wholly-owned subsidiary to enhance investment risk management[17]. - A proposal to establish a wholly-owned subsidiary in Taizhou with a registered capital of RMB 1 million was approved, but registration has been suspended due to business development adjustments[18]. - The company has completed the deregistration of five subsidiaries as part of its business development needs[19]. - The company is currently undergoing legal proceedings involving a claim of RMB 316.05 million and associated interest[19]. Financial Ratios and Metrics - The weighted average return on equity decreased by 0.33% to 0.79% compared to 1.12% in the same period last year[3]. - The company's inventory as of March 31, 2023, was CNY 405,260,935.46, slightly down from CNY 413,034,354.70 at the start of the year, indicating a decrease of approximately 1.84%[22]. - The company's capital reserve increased to CNY 1,446,574,558.13 from CNY 1,444,524,472.76, showing a growth of about 0.14%[24]. - The company’s total equity as of March 31, 2023, was CNY 1,593,494,920.72, a slight increase from CNY 1,591,111,592.85 at the beginning of the year, representing a growth of approximately 0.15%[24]. - The company reported a basic and diluted earnings per share of CNY 0.01, down from CNY 0.02 in the same quarter last year[27]. Financial Expenses - Financial expenses increased by 258.31% to ¥1,100.95 million due to higher exchange losses compared to the same period last year[9]. - The company reported a financial expense of CNY 15,271,516.92 for the first quarter, which is significantly higher than CNY 4,262,045.77 in the previous year, reflecting an increase of approximately 258%[26]. Tax and Refunds - The company received CNY 45,947.89 in tax refunds, significantly lower than CNY 1,717,432.60 received in the previous year[30]. Audit and Mergers - The company did not conduct any mergers or acquisitions during the reporting period, and the report was not audited[32].

Revenue and Profit - Revenue for Q3 2022 reached ¥628,920,239.19, an increase of 17.21% year-over-year, while year-to-date revenue was ¥2,028,858,436.64, up 22.36% compared to the same period last year[4] - Net profit attributable to shareholders was ¥1,334,719.69, a decrease of 74.46% year-over-year, with year-to-date net profit at ¥44,249,710.35, an increase of 14.19%[4] - Basic earnings per share for Q3 2022 were ¥0.0012, down 76.92% year-over-year, while diluted earnings per share were also ¥0.0012, showing the same decline[4] - Net profit for the current period was ¥47,172,900.31, compared to ¥43,336,196.24 in the previous period, reflecting an increase of approximately 6.3%[26] - The net profit attributable to the parent company shareholders for Q3 2022 was ¥44,249,710.35, an increase from ¥38,749,901.96 in the same period last year, representing a growth of approximately 3.86%[27] - The total comprehensive income for Q3 2022 was ¥46,634,781.79, compared to ¥51,229,088.00 in Q3 2021, indicating a decrease of about 8.91%[27] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was ¥304,272,487.38, reflecting a significant increase of 231.36%[4] - The net cash flow from operating activities for the period was ¥304,272,487.38, significantly up from ¥91,825,044.89 in the previous year, marking an increase of approximately 231.36%[29] - Cash and cash equivalents at the end of Q3 2022 stood at ¥551,080,662.03, down from ¥640,302,877.54 at the beginning of the period, reflecting a decrease of about 13.88%[30] - The total cash inflow from operating activities was ¥2,108,576,095.54, compared to ¥1,692,950,522.51 in the same period last year, showing an increase of approximately 24.48%[29] - The company experienced a 99.39% decrease in cash inflow from investment activities, reflecting a reduction of ¥30,846.33 million compared to the previous year[12] - The net increase in cash and cash equivalents decreased by 441.51% compared to the same period last year, with an absolute decrease of 115.35 million RMB, primarily due to the net cash flow from operating activities being less than the decrease in cash flow from investing and financing activities[14] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,867,581,511.42, a decrease of 4.96% from the end of the previous year[4] - The total assets decreased to ¥3,867,581,511.42 from ¥4,069,421,166.85, a decline of about 5%[23] - Total liabilities decreased to ¥2,033,000,441.55 from ¥2,232,686,402.91, showing a reduction of approximately 8.9%[23] - Current assets totaled ¥1,994,776,202.20, down from ¥2,183,321,715.52, indicating a decrease of about 8.6%[22] - Cash and cash equivalents were reported at ¥623,984,340.39, a decrease from ¥676,870,643.54, reflecting a decline of approximately 7.8%[22] - Accounts receivable decreased to ¥696,286,897.17 from ¥741,811,792.81, a reduction of about 6.1%[22] - Inventory levels dropped to ¥365,008,925.70 from ¥505,645,822.70, indicating a significant decrease of approximately 28%[22] - The company reported a decrease in long-term borrowings to ¥23,997,035.01 from ¥65,097,319.44, a decline of about 63.2%[23] Operating Costs and Expenses - The company reported a 50.18% increase in operating costs year-over-year, amounting to an absolute increase of ¥39,387.37 million, primarily due to higher revenue[10] - Total operating costs amounted to ¥1,952,142,934.10, up from ¥1,567,103,646.91, indicating a rise of about 24.5%[26] - Research and development expenses decreased by 39.20% year-over-year, totaling an absolute reduction of ¥9,571.14 million[10] - The cash outflow for purchasing goods and services was ¥844,889,768.27, up from ¥693,630,425.40 in the previous year, indicating an increase of about 21.83%[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 67,614, with no preferred shareholders restoring voting rights[16] - The largest shareholder, Beiyinmei Group Co., Ltd., holds 18.65% of shares, amounting to 201,418,500 shares, with 194,850,000 shares pledged[16] - The company has repurchased a total of 15,758,586 shares, accounting for 1.46% of the total share capital, which are held in a dedicated repurchase account[17] Strategic Initiatives - The company supports the establishment of an industrial incubation fund by its wholly-owned subsidiary to enhance the integration of industry and finance, with plans to acquire projects that align with its development strategy once they mature[18] - The company transferred 48% of its stake in Guangxi Quanan Sheng Enterprise Management Co., Ltd., which is no longer included in the consolidated financial statements[19] - The company will calculate financial assistance interest at an annualized rate of 5% based on the actual amount and duration of funds used by Guangxi Quanan Sheng[19] Other Information - The company has not disclosed any significant changes in user data or new product developments in this report[21] - The company did not report any net profit from subsidiaries prior to consolidation for the current and previous periods[27] - The company’s other comprehensive income for Q3 2022 was -¥538,118.52, a significant decline from ¥7,892,891.76 in the same period last year[27]

Financial Performance - The company's revenue for Q1 2022 was ¥696,112,450.13, representing a 22.80% increase compared to ¥566,858,555.71 in the same period last year[4] - Net profit attributable to shareholders was ¥20,126,374.67, up 38.45% from ¥14,537,381.04 year-on-year[4] - The net profit after deducting non-recurring gains and losses surged by 266.35% to ¥15,517,744.73 from ¥4,235,790.79 in the previous year[4] - Basic earnings per share doubled to ¥0.02 from ¥0.01 year-on-year[4] - The total operating revenue for the first quarter of 2022 was CNY 696,112,450.13, an increase of 22.8% compared to CNY 566,858,555.71 in the same period last year[23] - The net profit attributable to the parent company was CNY 20,126,374.67, compared to CNY 14,537,381.04, representing a year-on-year increase of 38.5%[24] Cash Flow and Liquidity - Operating cash flow increased by 145.02% to ¥52,895,828.43, compared to ¥21,588,202.87 in the same quarter last year[4] - Cash inflows from operating activities increased by 12.31% to ¥70,974,000.00, driven by higher sales revenue[11] - The net cash flow from operating activities was CNY 52,895,828.43, significantly higher than CNY 21,588,202.87 in the previous year[26] - The cash and cash equivalents at the end of the period totaled 606,082,937.03 CNY, a decrease from 640,302,877.54 CNY at the beginning of the period[27] - The net increase in cash and cash equivalents decreased by 140.69% to ¥-2000,250.00, primarily due to lower net cash from operating activities compared to investment and financing activities[12] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,112,136,081.48, a 1.05% increase from ¥4,069,421,166.85 at the end of the previous year[4] - The total current assets reached CNY 2,215,784,592.47, slightly up from CNY 2,183,321,715.52 at the start of the year[19] - The total liabilities increased to CNY 2,257,924,509.83 from CNY 2,232,686,402.91, indicating a rise of 1.1%[23] - The total equity attributable to shareholders of the parent company was CNY 1,802,455,204.51, compared to CNY 1,785,836,479.80, showing a growth of 0.9%[23] Operating Costs and Expenses - The company's operating costs rose by 43.50% to ¥38,487,000.00, reflecting the increase in revenue[9] - The total operating costs amounted to CNY 655,206,625.73, up from CNY 543,555,353.94, reflecting a growth of 20.5%[23] - The company incurred research and development expenses of CNY 4,553,454.36, slightly down from CNY 4,754,671.25[23] Investments and Financing Activities - The company established a joint venture, Yibei Intelligent (Hangzhou) Nutrition Technology Co., Ltd., with a registered capital of CNY 10 million, where the company holds a 40% stake[16] - The company repurchased 8,286,307 shares, accounting for 0.77% of the total share capital[15] - The company reported a total cash outflow from investment activities of 57,858,101.19 CNY in Q1 2022[27] - The cash outflow for debt repayment was 256,066,665.00 CNY, compared to 300,000,000.00 CNY in the previous year[27] Other Financial Metrics - The company reported a significant decrease in financial expenses by 73.56%, amounting to ¥426,000.00, due to reduced exchange losses[9] - The company reported a decrease in other comprehensive income, with a net amount of CNY -3,842,449.96 compared to CNY -1,396,328.67 in the previous year[24] - The company did not undergo an audit for the Q1 2022 report[28]

Financial Performance - The company's operating revenue for 2022 was ¥2,654,624,655.97, an increase of 4.53% compared to ¥2,539,560,089.66 in 2021[6]. - The net profit attributable to shareholders was -¥175,996,805.92, a decrease of 340.06% from ¥73,314,574.33 in the previous year[6]. - The cash flow from operating activities increased by 52.96% to ¥377,416,659.60 from ¥246,743,802.53 in 2021[6]. - The basic earnings per share for 2022 was -¥0.16, down 328.57% from ¥0.07 in 2021[6]. - Total assets at the end of 2022 were ¥3,877,108,863.41, a decrease of 4.73% from ¥4,069,421,166.85 at the end of 2021[6]. - The net assets attributable to shareholders decreased by 13.84% to ¥1,538,639,572.79 from ¥1,785,836,479.80 in 2021[6]. - The company reported a significant loss in the fourth quarter with a net profit attributable to shareholders of -¥220,246,516.27[31]. - The company is facing uncertainty regarding its ability to continue as a going concern, as indicated by negative net profits over the last three years[6]. Market and Product Development - The company is committed to expanding its market presence and sales scale despite industry challenges[5]. - The main product category, infant formula, generated a revenue of 2.276 billion CNY, with a year-on-year increase of 7.55%[42]. - The company is focusing on expanding its product matrix with innovative products like the "珍质系列" and "叶酸龙凤太" to meet evolving consumer demands[44]. - The company plans to launch three new product lines in 2023, focusing on organic and health-oriented products to meet market demand[111]. - The company has completed the registration of 10 key series and 30 products under the new national standards, with ongoing registration for other products[44]. - The infant formula market in China is expected to see significant growth, particularly in lower-tier cities, driven by increasing consumer trust in domestic products[44]. Cost Management and Operational Efficiency - The company plans to enhance cost management and expense control to improve competitiveness amid high operational costs[5]. - The operating cost for 2022 was 1.5034407 billion yuan, reflecting a year-on-year increase of 11.54%[55]. - The gross profit margin decreased to 43.37%, down 3.55 percentage points compared to the previous year, primarily due to increased sales discounts and rising raw material prices[55]. - The company aims to enhance operational efficiency by optimizing its industrial layout and reducing operational costs through standardized systems and information processes[105]. Corporate Governance and Compliance - The company is committed to improving corporate governance and transparency, ensuring compliance with all regulatory requirements[112]. - The company established an insider information reporting system to comply with regulations during the preparation of periodic reports[120]. - The company has strengthened its institutional framework to enhance decision-making processes for external investments, ensuring the protection of investors' rights[121]. - The independent auditor, Dahua Certified Public Accountants, issued an unqualified audit report with emphasis on certain matters for the fiscal year 2022, reflecting the company's financial status accurately[189]. Research and Development - The company is investing 200 million yuan in research and development for new technologies aimed at improving product quality and safety standards[111]. - The number of R&D personnel increased by 17.24% to 34, with a higher proportion of master's degree holders[75]. - The company focused on developing new infant formula products and innovative nutritional products to meet family health needs[74]. Social Responsibility and Community Engagement - The company donated over 2.6 million yuan to various charitable organizations during the reporting period[173]. - Beiyinmei's mission focuses on helping babies grow healthily, supporting mothers, and promoting family happiness[173]. - The company has been actively involved in social welfare projects, including the "Love Baby" and "Parenting" initiatives since 1993[173]. Employee Management and Compensation - The total number of employees at the end of the reporting period is 2,095, with 1,020 in the parent company and 1,075 in major subsidiaries[151]. - Employee compensation consists of basic salary, performance pay, and welfare allowances, with a strong link between performance results and income[152]. - The company has implemented stock option incentive plans to enhance employee satisfaction and loyalty[152]. Strategic Partnerships and Collaborations - The company is enhancing its collaboration with channel partners to explore strategic and capital cooperation opportunities[45]. - The company has established a joint venture with an investment of 15.51 million RMB, enhancing its operational capabilities[103]. - The company is actively exploring collaborations within the maternal and child ecosystem to strengthen its core business while expanding service offerings[104]. Financial Management and Investments - The company reported a total investment of ¥90,682,123.70 during the reporting period, a decrease of 12.28% compared to the previous year's investment of ¥103,381,626.03[87]. - The company has fully utilized the raised funds of ¥252,304,573.30 by the end of 2022, with a remaining balance of ¥649,985.00[93]. - The company has not reported any issues or problems regarding the use and disclosure of raised funds[97].

证券代码：002570 证券简称：贝因美 贝因美婴童食品股份有限公司 投资者关系活动记录表 编号：20140919 号 | --- | --- | --- | --- | --- | |-------------------------|----------------------------|----------------------------------------------------------------|-------|-----------| | 投资者关系活动 | | █特定对象调研 □分析师会议 | | | | 类别 | □媒体采访 | □业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | | □其他 | （请文字说明其他活动内容） | | | | 参与单位名称及 | 安信证券 张龙 | | | | | 人员姓名 | 长信基金 刘亮 | | | | | | 国联安基金 | 林静 | | | | | 本次调研共有 3 | 位投资者参与 | | | | 时间 2014 | 年 9 月 19 日 | 10：00-11：30 | | ...